Application Note

An Environmental Life Cycle Comparison Of Single-Use And Conventional Bioprocessing Technology

Source: GE Healthcare Life Sciences

Biopharmaceutical development and manufacturing demand scalable processes that can be smoothly transferred to production. These processes need to be quickly developed and easy to implement. Ready-to-use technologies such as the ReadyToProcess™ platform from GE Healthcare Life Sciences play a crucial role in providing the flexibility to support multiproduct facilities and deliver process time savings, allowing for faster changeover between products. The Ready ToProcess platform is a complete suite of preconditioned systems and accessories for biopharmaceutical production, prepared for immediate use. The platform includes both single-use and reusable products.